Abstract:
This study was a descriptive cross sectional study which aimed to evaluate the role of U/S and fPSA in differentiation between benign prostatic hyperplasia and prostatic carcinoma, carried out in Elribat hospital (renal unit) from November 2016 to February 2017.
There were 50 patients were scanned transabdominal using Aloka and Toshiba U/S machines. All patients had benign prostatic hyperplasia or prostatic carcinoma and referred by physician. Any patient had normal prostate or prostatitis was excluded from this study.
Firstly ultrasound scanning was done for patients to evaluate AP diameter, transverse, thickness, volume shape and echo-texture of the prostate. Then tPSA and fPSA were done to all patients, finally histopathology was done for all patients.
Data was collected using data collected sheets and analyzed using SPSS program. Study found that there were 60% of patients had benign prostatic hyperplasia, while other (40%) patients had prostatic cancer. Also study showed there were 32 patients (64%) out of 50 cases had normal shape, 30 patients( 60%) of them had benign prostatic hyperplasia, 2 patients (4%) had cancer. 34patients (68%) out of 50 had presence of calcification.
Study concluded that using ultrasound and fPSA was accurate that tPSA in differentiation between benign prostatic hyperplasia and prostatic cancer or any tool alone.
The Study recommended that ultrasound scanning should be done routinely for any patient had age more than forty.
